Joshua Levin

Company: GlaxoSmithKline

Job title: Director, Precision Medicine & Digital Health

Seminars:

Roundtable Discussion:Navigating FDA Regulatory Pathways to Accelerate Liquid Biopsy Approval & Adoption 3:30 pm

What are the key FDA regulatory requirements for liquid biopsy assays, and how do they differ for companion diagnostics versus standalone tests? How can developers navigate the evolving FDA landscape, including the impact of recent LDT regulations on liquid biopsy commercialization? What strategies can companies use to engage with the FDA early, streamline approval pathways,…Read more

day: Conference Day 2